drugset / Trial / NCT03678649
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
RandomizedParallel-groupOpen-labelTreatment
Summary
This prospective randomized controlled clinical Trial will be performed in patients with locally advanced squamous cell carcinoma of the head and neck. The objectives of the trial are to compare the efficacy and safety of Capecitabine treatment with placebo as adjuvant therapy to patients who have received radiotherapy.
Timeline
- Start
- 2018-09-10
- Primary completion
- 2020-12-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |